Effect of fluoride on postmenopausal osteoporosis

John A. Kanis, Lawrence E. Mallette, B. Lawrence Riggs, Stephen F. Hodgson, W. Michael O'fallon, Edmund Y.s. Chao, Heinz W. Wahner, Joan M. Muhs, Sandra L. Cedel, L. Joseph Melton

Research output: Contribution to journalLetter

7 Scopus citations

Abstract

To the Editor: The risks and benefits of fluoride treatment for osteoporosis have been the subject of much controversy, fueled by a lack of adequately controlled, prospective, randomized, blinded studies. Although such shortcomings cannot be attributed to the study recently reported by Riggs et al. (March 22 issue),1 there are several aspects of its design that suggest that the risks of fluoride therapy may have been magnified and the potential benefits minimized. The risks appear to fall into three major categories — namely, gastrointestinal intolerance, osteoarticular pain, particularly of the lower extremities, and appendicular fractures. The first two appear to.

Original languageEnglish (US)
Pages (from-to)416-417
Number of pages2
JournalNew England Journal of Medicine
Volume323
Issue number6
DOIs
StatePublished - Aug 9 1990

    Fingerprint

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Kanis, J. A., Mallette, L. E., Riggs, B. L., Hodgson, S. F., O'fallon, W. M., Chao, E. Y. S., Wahner, H. W., Muhs, J. M., Cedel, S. L., & Melton, L. J. (1990). Effect of fluoride on postmenopausal osteoporosis. New England Journal of Medicine, 323(6), 416-417. https://doi.org/10.1056/NEJM199008093230612